Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
CACI
CACI
$14.2B
| $9.5M | ﹤0.01% |
31,620
+1,801
| +6% | +$525K |
|
1227
Intuitive Machines
LUNR
$2.63B
| $9.5M | ﹤0.01% |
950,000
-97,274
| -9% | -$964K |
|
|
OSH
1228
DELISTED
Oak Street Health, Inc.
OSH
| $9.5M | ﹤0.01% |
441,558
-77,738
| -15% | -$1.63M |
|
|
EQC
1229
DELISTED
Equity Commonwealth
EQC
| $9.5M | ﹤0.01% |
380,327
-115,372
| -23% | -$2.95M |
|
1230
PUT
Occidental Petroleum
OXY
$55.9B
| $9.45M | ﹤0.01% |
+150,000
| New | +$10.2M |
|
1231
PUT
Ally Financial
ALLY
$13.3B
| $9.34M | ﹤0.01% |
+382,000
| New | +$10.2M |
|
1232
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
| $9.33M | ﹤0.01% |
+125,200
| New | +$9.12M |
|
1233
CALL
Marathon Petroleum
MPC
$83.7B
| $9.31M | ﹤0.01% |
+80,000
| New | +$9.12M |
|
|
JBTM
1234
JBT Marel
JBTM
$6.39B
| $9.3M | ﹤0.01% |
101,780
+9,420
| +10% | +$862K |
|
1235
PUT
Applovin
APP
$116B
| $9.28M | ﹤0.01% |
881,600
+681,600
| +341% | +$10M |
|
1236
Ares Management
ARES
$30.9B
| $9.28M | ﹤0.01% |
135,526
+108,259
| +397% | +$7.81M |
|
1237
CALL
Coca-Cola
KO
$375B
| $9.27M | ﹤0.01% |
+145,700
| New | +$8.8M |
|
1238
PUT
Pinterest
PINS
$13.4B
| $9.23M | ﹤0.01% |
+380,000
| New | +$9.06M |
|
1239
PUT
Rivian
RIVN
$23.2B
| $9.21M | ﹤0.01% |
+500,000
| New | +$14.7M |
|
1240
Li Auto
LI
$12.7B
| $9.2M | ﹤0.01% |
450,741
-135,565
| -23% | -$2.58M |
|
1241
PUT
Restaurant Brands International
QSR
$25.8B
| $9.18M | ﹤0.01% |
+142,000
| New | +$8.73M |
|
1242
BridgeBio Pharma
BBIO
$16.5B
| $9.16M | ﹤0.01% |
1,201,885
+875,468
| +268% | +$8.38M |
|
1243
United Microelectronic
UMC
$46.9B
| $9.15M | ﹤0.01% |
1,401,223
+199,663
| +17% | +$1.32M |
|
1244
Teva Pharmaceuticals
TEVA
$41.2B
| $9.15M | ﹤0.01% |
1,002,844
+128,177
| +15% | +$1.12M |
|
1245
PUT
Amgen
AMGN
$222B
| $9.09M | ﹤0.01% |
+34,600
| New | +$9.27M |
|
1246
Intellia Therapeutics
NTLA
$1.67B
| $9.07M | ﹤0.01% |
259,867
+75,296
| +41% | +$3.58M |
|
1247
TD Synnex
SNX
$20.2B
| $9.05M | ﹤0.01% |
95,533
+44,979
| +89% | +$4.21M |
|
1248
Harley-Davidson
HOG
$2.71B
| $9.01M | ﹤0.01% |
216,580
-8,371
| -4% | -$356K |
|
|
NS
1249
DELISTED
NuStar Energy L.P.
NS
| $9M | ﹤0.01% |
562,550
-206,947
| -27% | -$3.22M |
|
1250
PUT
iShares Biotechnology ETF
IBB
$9.77B
| $8.98M | ﹤0.01% |
+68,400
| New | +$8.84M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.